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Parasite of the genus Leishmania is reliant on the salvage pathway for recycling of ribonucleotides. A class I nuclease enzyme also
known as P4 nuclease is involved in salvage of purines in cutaneous Leishmania species but the relevant enzymes have not been
characterized in Leishmania infantum (L. infantum). The aim of this study was to clone and characterize the gene encoding class
I nuclease in L. infantum.D N Ae x t r a c t e df r o mL. infantum was used for ampliﬁcation of P4 nuclease gene (Li-P4) by PCR. The
product was cloned, sequenced, and expressed in E. coli for further characterization. Analysis of the sequence of Li-P4 revealed
that the gene consists of an ORF of 951bp. Sequence similarity analysis indicated that Li-P4 has a high homology to relevant
enzymes of other kintoplastids with the highest homology (88%) to p1/s1 class I nuclease from L. donovani. Western blotting of
antirecombinant Li-P4 with promastigote and amastigote stages of L. infantum showed that this nuclease is present in both stages
ofparasitewithhigherexpressioninamastigotestage.ThehighlyconservednatureofthisessentialenzymeinLeishmaniaparasites
suggests it as a promising drug target for leishmaniasis.
1.Introduction
Protozoan parasites of the genus Leishmania cause a spec-
trum of clinical disease, including cutaneous, mucocuta-
neous, and visceral leishmaniasis (VL). Approximately 12
million people are infected with this parasite worldwide
with 1.5–2 million new cases occurring each year [1].
Leishmania parasites are dimorphic organisms which exist
as promastigotes in extracellular stage and in the sandﬂy
midgut, and as amastigote that lives intracellularly in the
phagolysosomes of macrophages in the mammalian host
cells [2, 3]. Unfortunately, currently available treatment
regimens are nonselective drugs with signiﬁcant toxicity and
limited eﬃcacy [4, 5]. On the other hand, eﬀorts aimed at
the development of vaccines have only achieved low levels of
protection in trials in human subjects [6, 7]. Thus, there is
an urgent need to identify novel molecular targets that can
be exploited for drug development, vaccine design, or both.
Purine salvage pathway seems as an attractive target for drug
development against Leishmania. Trypanosomatid protozoa
such as Leishmania are purine auxotrophs and are totally
dependent upon their hosts to provide purine nucleotides
for their survival, growth, and multiplication [8, 9]. It has
shown that Leishmania promastigotes possess a unique class
I nuclease, [10, 11] that involves the salvage of preformed
purines through the hydrolysis of either 3 -nucleotides or
nucleic acids [12–16]. An intracellular amastigote-speciﬁc
protein, P-4, with class I nuclease activity has also been2 Enzyme Research
identiﬁed in L. pifanoi by Kar et al. [17]a n db yo u rg r o u p
in L. major [18]. However, there was no data about the
presence and characteristics of this nuclease in L. infantum,
thecausativeagentofinfantilehumanleishmaniasis.Theaim
of this study was to clone and characterize the P4 nuclease
from Leishmania infantum.
2.MaterialsandMethods
2.1. Parasite and DNA Extraction. In this study, Iranian
strain of Leishmania infantum was used. Promastigotes were
cultured at 26◦C in RPMI 1640 medium with glutamine
(Gibco BRL) supplemented with 10% heat-inactivated fetal
calf serum (Sigma-Aldrich). Organisms were harvested in
logarithmic phase and washed with phosphate buﬀer saline
( P B S ,p H7 . 2 ) .P a r a s i t e sw e r ed i s r u p t e di nl y s i sb u ﬀer
(50mM NaCl, 50mM EDTA, 1% SDS, 50mM Tris-HCl, pH
8.0) and incubated overnight with proteinase K (100mg/mL,
Sigma-Aldrich) at 37◦C. DNA was then puriﬁed by phenol-
chloroform extraction and ethanol precipitation.
2.2. PCR Ampliﬁcation. Ap a i ro fp r i m e r sw a sd e s i g n e d
b a s e do nP 4g e n es e q u e n c ep r e v i o u s l yr e p o r t e df o r
cutaneous leishmaniasis (CL) strains: forward, 5 -
CATATGTGGGGCTGCGTGGGTCACAT-3  and reverse, 5 -
TACTCGAGCACCTCGCTTCGGACG-3  [19]. Each PCR
reaction contained 200ng DNA, 10p mol each of forward
and reverse primers, 1.5mM Mgcl2, 200μMd N T P s ,1×
PCR buﬀer, 2 unit of Pfu DNA polymerase (Fermentas) and
up to 25μL d H2O. PCR ampliﬁcation was carried out in
94◦C for 4min, followed by 30 cycles of denaturation at
94◦C for 1min, annealing at 60◦Cf o r6 0s e c ,a n de x t e n s i o n
at 72◦C for 60sec with a ﬁnal extension cycle at 72◦Cf o r
20min. PCR products were electrophoresed on 1.5% agarose
gel and stained by ethidium bromide. The DNA bands were
visualized under an ultraviolet light (UV transilluminator)
and documented.
2.3. Gene Cloning. The PCR product was puriﬁed by
PCR product puriﬁcation kit (Roche) and ligated into the
pGEM-T easy vector (Promega). The ligation reaction was
transformed into DH5α (Promega) competent cells and
plated on Luria-Bertani (LB) agar, containing ampicillin
(50mg/mL), 5-bromo-4 chloro-3-indolyl-β-D-galactoside
(X-gal: 20mM), and Isopropyl thio-β-D-galactoside (IPTG:
200mg/mL). The white colonies containing recombinant
plasmid were selected [20] for plasmid extraction and PCR
screening [21]. Then cloning was veriﬁed by restriction
digestion and sequencing.
2.4. Expression and Puriﬁcation. The pGEM vector contain-
ing Li-P4 gene was digested with Nde I and Xho I and the
insert was puriﬁed, subcloned into the Nde I - Xho I digested
pET28a (Novagen) expression vector and transformed into
the E. coli BL21 (Novagen). The bacteria containing pET28a-
Li-P4 was cultured in LB broth medium and grown until
OD = 0.5. Expression of recombinant P4 was induced
by addition of 25μL of 1mM IPTG then incubated for
further 4h at 37◦C and analyzed by SDS-PAGE [22]. For
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Figure 1: Ampliﬁcation of P4 nuclease gene of Leishmania infan-
tum. Lane 1 and Lane2: 951bp Li-P4 gene PCR product, Lane 3: no
DNA, and Lane 4: 1Kb DNA Ladder.
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Figure 2: Cloning of Li-P4 nuclease gene in pGEM-t vector.
Lane 1: undigested recombinant plasmid, Lane 2: Eco RI-digested
recombinant plasmid, Lane 3: 1kb DNA ladder.
puriﬁcation of recombinant Li-P4, E. coli BL21 containing
expression vector was cultured in 1 liter LB broth medium,
and following induction with IPTG, the pellet was collected
by centrifugation. The bacterial sediment was disrupted in
5mL lysis buﬀer (PH = 8, 50mM NaH2PO4, 300mM
NaCl) by sonication, centrifuged for separation of soluble
and insoluble fraction and analyzed by SDS-PAGE. Since
the recombinant protein was expressed as 6 His-tag fusion,
the Ni-NTA column (Qiagen) was used for puriﬁcation.
Brieﬂy, Li-P4 inclusion body was dissolved in lysis buﬀer
containing 8M urea and passed through Ni-NTA column
that previously equilibrated with related buﬀer. The column
was washed and recombinant protein was released and
collected using 250mM Imidazol. The puriﬁed protein then
was dialysed against PBS and used for further experiments.Enzyme Research 3
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Figure 3: Alignment of deduced amino acid sequence of L. infantum amastigote P4 with class I nuclease from L. donovoni (GeneBank
Accessionno.ABE69185.1),L.major (Accessionno.XP 001684745.1),L.amazonensis(Accessionno.AAO65599.1),andL.pifanoi(Accession
no. AAD48894.2). 5 conserved domains along with several semiconsereved domains between this nuclease are indicated by continuous stars.
Results of puriﬁcation were controlled by %10 SDS-PAGE
gels.
2.5. Production of Rabbit Antiserum against Recombinant Li-
P4. An adult rabbit (New Zealand White) was immunized
subcutaneously with 200mg of puriﬁed rL-iP4 emulsiﬁed
in an equal volume of complete Freund’s adjuvant (CFA)
(Sigma-Aldrich), followed by a subcutaneous boosting 2
weeks later with 100μg of recombinant P4 protein in
incomplete Freund’s adjuvant (IFA) (Sigma-Aldrich). Two
weeks later, the rabbit was boosted intravenously with 50μg
of rLiP4, and blood was collected 1 week later.
2.6. Western Blotting. For determination of P4 nuclease,
lysates of promastigotes and amastigotes of L. infantum
were incubated with rabbit antiserum raised against rLi-P4
followed by incubation in 1/5000 dilution of HRP conju-
gated goat antirabbit IgG (Sigma-Aldrich). After washing
to remove unbound antibodies, membranes were incubated
in 1/5000 dilution of HRP conjugated goat antirabbit IgG
(Sigma) and processed for ECL. The protocol for detection
of Leishmania elongation factor-1a (as an internal control)
in lysates of promastigotes and amastigotes using mouse
monoclonal anti-EF-1a and HRP-conjugated antimouse IgG
w a sa sd e s c r i b e dp r e v i o u s l y[ 23].
3. Results and discussion
3.1. Gene Cloning. After culture, the Leishmania infantum
was subjected to DNA extraction and Li-P4 gene ampliﬁca-
tion.PCRampliﬁcationofP4nucleasegenefromL.infantum
results in a PCR product of 951bp that was in expected size
(Figure 1). The PCR product was cloned in the pGEM-T
easy vector using T-A cloning method and conﬁrmed by
restriction digestion (Figure 2).
3.2. Sequencing and Multiple Alignments. Li-p4 was ampli-
ﬁed from L. infantum amastigote using forward and reverse
primers based on the sequence previously reported for
cutaneous leishmaniasis (CL) strains. The PCR product was4 Enzyme Research
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Figure 4: Phylogenetic tree of P1/S1 nuclease gene sequences
among species of Leishmania. This tree shows the relatedness
between P4 nuclease from L. infantum and P1/S1 nuclease L.
donovani.
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Figure 5: Cloning Li-P4 nuclease gene in pET 28a vector. Lane 1
and 3: recombinant plasmid, undigest, Lane 2 and 4: Nde I - Xho I
digested recombinant plasmid, and Lane 5: 1Kb DNA Ladder.
cloned into the pGEM-T easy vector and sequenced. The
nucleotide sequence was submitted to the GeneBank/NCBI
Data Base under accession number ABY27514.1. Result of
sequencing revealed that the gene consists of an ORF of
951 base pairs with a predicted molecular mass of 33kDa.
Structural analysis using Signal P software showed a signal
sequence consisting of the ﬁrst 30 amino acids and two
putative N-linked glycosylation sites (at amino acid residues
108 and 251). A search of the SWISSPRO database with the
predicted amino acid sequence revealed a signiﬁcant similar-
ity to a number of proteins belonging to the Class I nuclease
family as shown by the alignment using the ClustalW
program (Figure 3)[ 24]. The protein with highest similarity
to P4 nuclease was P1/S1 secretory nuclease of L. donovani
(GenBank accession no. ABE69185.1) [23]( Figure 4). Other
proteins with signiﬁcant similarity were: p1/s1 nuclease
of L. major (accession no. XP 001684745.1) [18], single-
strand-speciﬁc nuclease from L. pifanoi (accession no.
AAD48894.2), and P4 nuclease of L. amazonensis (accession
no. AAO65599.1); identities and positivities between Li-P4
nuclease and each of these proteins are shown in Table 1.
Analysis of the sequences for conserved domains using the
NCBI protein blast tool showed that in spite of some hetero-
geneity in primary structure,all of these proteins contained a
conserved nuclease domain speciﬁc to class I nuclease family.
3.3. Expression and Puriﬁcation of Recombinant P4 Nuclease.
For expression of recombinant Li-P4, the PCR product was
1234
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Figure 6: SDS-PAGE analysis of recombinant Li-P4 produced in
BL21, Lane 1: bacterial lysate before induction, Lane 2: bacterial
lysate after induction with IPTG, Lane 3: puriﬁed recombinant Li-
P4, and Lane 4: molecular weight marker.
Table 1: Similarity of predicted amino acid sequence of Li-P4
nuclease with diﬀerent promastigote-speciﬁc P1/S1 nuclease of
various Leishmania species.
Leishmania species Identity %∗ Positivity %∗∗
P4 nuclease (Leishmania infantum) 100 100
P1/S1 secretary nuclease (Leishmania
donovani) 89 92
p1/s1 nuclease (Leishmania major)8 1 8 9
single strand-speciﬁc nuclease
(Leishmania pifanoi) 77 85
P4 nuclease (Leishmania
amazonensis) 75 85
∗Identity is referred to the extent to which two sequences are invariant.
∗∗Positivity is referred to the extent to which two sequences possess amino
acids with the same physicochemical properties.
subcloned in the NdeI-XhoI site of pET28a (Novagen) in
frame with C-terminal 6His-tag and transformed into the
E. coli Bl21 (Figure 5). Induction of recombinant protein
expressionbyIPTGresultedinahighlevelofexpression.The
molecular mass was found to be 33kDa, which was slightly
higherthanthenativematureproteinduetotheadditionofa
Hexa-His-tag sequence. Puriﬁcation of recombinant protein
was performed by aﬃnity chromatography on Ni-NTA resin,
and fractions were analyzed by SDS-PAGE (Figure 6).
3.4. Diﬀerential Expression of P4 Protein in the Amastigotes.
To examine further developmental regulation of expression
of P4 nuclease in L. infantum, polyclonal rabbit antisera
raised against recombinant Li-P4 were used to probe western
blots containing lysates of promastigotes and amastigotes
of L. infantum. As shown in Figure 7(a),as t r o n g l yr e a c t i v e
band of the expected mass (33kDa) was observed in lysates
of amastigotes (lane 3) but appeared fairly in lysates of
procyclic or metacyclic promastigotes (lane 1 and 2, resp.).Enzyme Research 5
123
P4 nuclease
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123
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Figure 7:AnalysisofP4geneexpressionindiﬀerentlifecyclestagesofL.infantum.(a)Promastigoteandamastigotecelllysateswereanalyzed
by immunoblotting using rabbit anti-recombinant Li-P4. Lane 1: Log phase promastigotes. Lane 2: Stationary phase promastigotes. Lane 3:
Amastigotes. (b) The same blot as in a was probed with rabbit anti Elongation Factor 1-alfa antibody. The results indicate higher expression
of P4 nuclease in amastigote stage of parasite.
To ensure that equivalent amounts of promastigote and
amastigote proteins were loaded and transferred for detec-
tion, a similar blot was incubated with monoclonal antibody
against EF-1α (Upstate Biotechnology, USA), a protein that
isexpressedinalllifecyclestages(Figure 7(b)).Asitisshown
in Figure 7(b), the abundance of EF-1α in promastigote
samples (lane 1 and 2) was similar to that one in amastigote
lysates (lane 3).
P-4 is a single-stranded speciﬁc class I nuclease that
was identiﬁed initially in L. amazonensis [16] and then
characterized in L. pifanoi by Kar et al. [17]. Recently, we
isolated a class I nuclease gene from amastigotes of L. major
[18]. In the present study we characterized this nuclease in
L. infantum. Similarity analysis revealed that the sequence of
corresponding protein from L. infantum has high sequence
homology to the P4 nuclease of L. donovani, L. major,
L. Pifanoi, and 3
 -nucleotidase/nuclease enzymes previously
described in diﬀerent trypanosomatids [11]. The alignment
results indicated the presence of 5 main conserved domains
between these nucleases from diﬀerent species.
The class I nuclease from promastigote stage of some
Leishmania species have been extensively studied [8, 13, 19,
25, 26]. It has shown that expression of this nuclease upregu-
lated signiﬁcantly in response to purine starvation [13, 17]
which is consistent with the opinion that class I nuclease
enzyme plays a vital role in providing purines for growth
and development of Leishmania parasites. Since there is no
a homologue enzyme with similar properties in mammalian
tissues, this enzyme can serve as a chemotherapeutic target
for selective targeting of Leishmania during infection [11].
Considering that Leishmania is present as amastigotes in
mammalian tissues and this stage is responsible for disease
manifestations, the higher expression of the class I nuclease
in amastigote stage further supports the use of this enzyme
as a target.
4. Conclusion
In conclusion, the results of the present study revealed
that Li-P4 nuclease belongs to the class I nuclease group
of enzymes that are highly expressed in amastigote stage
of L. infantum and could be exploited as target for
chemotherapy.
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